BOCA RATON, Fla., April 07, 2016 -- The Securities Arbitration Law Firm of Klayman & Toskes, P.A. ("K&T"), www.nasd-law.com, announces that it is conducting an investigation into potential Financial Industry Regulatory Authority (FINRA) sales practice violations by brokerage firms for solicited investments in Franklin Square Energy and Power Fund (“FSEP”), a non-traded Business Development Company (“BDC”). FSEP assets, with assets in excess of $3.6 billion, are invested primarily in senior secured loans made to private companies focused in oil industry infrastructure for drilling and exploration. FSEP investors have experienced a decline in the value of the non-traded BDC Net Asset Value (NAV) along with the decline in the price of oil. According to K&T, the scope of the investigation includes whether brokerage firms made suitable recommendations related to FSEP and whether adequate disclosure was made concerning the syndication costs and risks of non-traded BDC concentrated in the energy sector.
A new regulatory notice, FINRA Notice to Members 15-02, effective April 11, 2016 instructs brokerage firms to provide greater disclosure concerning BDCs, such as FSEP on customer account statements. Securities attorney Lawrence Klayman, Esq. comments on the regulatory notice, ”Investors in Franklin Square’s Energy and Power Fund will now receive more accurate information disclosed on account statements, including deductions of 10% for distribution costs and changes in the value of the loan portfolio concentrated in the energy sector.” Mr. Klayman asserts, “Our investigation is to determine whether financial advisors failed to adequately disclose the risks related to concentration in the energy sector and the effects of syndication costs on the valuation of this BDC.”
FINRA sales practice rules related to potential violations may include misrepresentations and omissions of material facts, conflicts of interest, unsuitable investment advice, securities concentration, or failure to supervise its financial advisors. Our investigation relates to brokerage firms and its financial advisors’ recommended investments in Franklin Square Energy and Power Fund for customer accounts.
About Klayman & Toskes, P.A.
K&T is a leading national securities law firm which practices exclusively in the field of securities arbitration and litigation, on behalf of retail and institutional investors such as non-profit organizations, unions, public and multi-employer pension funds in large and complex securities matters. K&T has office locations in California, Florida, New York and Puerto Rico. If you wish to discuss this investigation or have knowledge of brokerage firm sales practices related to Franklin Square Energy and Power Fund can contact us, or call Steven D. Toskes, Esq. at 888-997-9956.
Contact: Klayman & Toskes, PA Steven D. Toskes, Esq. 888-997-9956 [email protected] www.nasd-law.com


Washington Post Publisher Will Lewis Steps Down After Layoffs
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



